Smith G H, Sharp R, Kordon E C, Jhappan C, Merlino G
Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4255, USA.
Am J Pathol. 1995 Oct;147(4):1081-96.
Transforming growth factor (TGF)-alpha stimulates the growth and development of mammary epithelial cells and is implicated in the pathogenesis of human breast cancer. In this report we evaluate the consequences of overexpressing TGF-alpha in the mammary gland of transgenic mice and examine associated cellular mechanisms. When operating on a FVB/N genetic background (line MT100), TGF-alpha induced the stochastic development of mammary adenomas and adenocarcinomas f secretory epithelial origin in 64% of multiparous females. In contrast, tumors were exceedingly rare in virgin MT100 females, MT100 males, and multiparous FVB/N females. In MT100 females multiple foci of hyperplastic secretory lesions preceded the development of frank tumors; these initial lesions appeared during the involution period after the first lactation. Serial transplantation of these hyperplasias indicated an absence of proliferative immortality. Nevertheless, they gave rise to tumors at a low frequency and after a prolonged latency in virgin hosts; in multiparous hosts, tumors developed earlier and at a high incidence. The TGF-alpha transgene was highly expressed in hyperplasias and tumors but not in virgin and nonlesion-bearing tissue, suggesting that TGF-alpha overexpression provides a selective growth advantage. TGF-alpha also induced at lactation a 6.4-fold increase in DNA synthesis in MT100 epithelial cells, many of which were binucleated. MT100 mammary tissue experienced an obvious delay in involution, resulting in the postlactational survival of a significant population of unregressed secretory epithelial cells. In contrast, another line of transgenic mice on a CD-1 genetic background (MT42), in which TGF-alpha overexpression induced liver but not mammary tumors, failed to demonstrate postlactational epithelial cell survival. These data show that TGF-alpha promotes mammary tumorigenesis in multiparous MT100 mice by stimulating secretory epithelial cell proliferation during lactation and prolonging survival during involution. These points support the notion that TGF-alpha can act as a mitogen and also as a differentiation factor in mammary epithelium.
转化生长因子(TGF)-α可刺激乳腺上皮细胞的生长和发育,并与人类乳腺癌的发病机制有关。在本报告中,我们评估了在转基因小鼠乳腺中过表达TGF-α的后果,并研究了相关的细胞机制。当在FVB/N遗传背景(MT100品系)下操作时,TGF-α在64%的经产雌性小鼠中诱导了分泌性上皮来源的乳腺腺瘤和腺癌的随机发生。相比之下,在未生育的MT100雌性小鼠、MT100雄性小鼠和经产FVB/N雌性小鼠中,肿瘤极为罕见。在MT100雌性小鼠中,多个增生性分泌性病变灶先于明显肿瘤的发生;这些初始病变出现在首次泌乳后的退化期。对这些增生组织进行连续移植表明不存在增殖性永生。然而,它们在未生育的宿主中以低频率并经过长时间潜伏期后引发肿瘤;在经产宿主中,肿瘤更早发生且发生率更高。TGF-α转基因在增生组织和肿瘤中高表达,但在未生育和无病变组织中不表达,这表明TGF-α过表达提供了选择性生长优势。TGF-α在泌乳期还使MT100上皮细胞中的DNA合成增加了6.4倍,其中许多细胞为双核。MT100乳腺组织的退化明显延迟,导致大量未退化的分泌性上皮细胞在泌乳后存活。相比之下,另一品系在CD-1遗传背景下的转基因小鼠(MT42),其中TGF-α过表达诱导肝脏肿瘤而非乳腺肿瘤,未表现出泌乳后上皮细胞存活。这些数据表明,TGF-α通过在泌乳期刺激分泌性上皮细胞增殖以及在退化期延长细胞存活来促进经产MT100小鼠的乳腺肿瘤发生。这些观点支持了TGF-α可在乳腺上皮中作为有丝分裂原和分化因子发挥作用的观点。